RFID: Revolutionizing Patient Monitoring? Rfid.org, PA - Nov 7, 2008 There is a lot of talk about RFID in healthcare -- from patient identification to medical equipment tracking to pharmaceutical and the supply chain safety ...
Silverman retakes control at VeriChip, tries to revive company South Florida Business Journal, FL - Nov 27, 2008 Without Xmark?s radio frequency identification (RFID) technology, VeriChip only has its implantable RFID business ? and that?s not likely to make money soon ...CHIP
VeriChip Corporation And RECEPTORS LLC Successfully Complete RFID Solutions Online (press release), PA - Nov 19, 2008 (BUSINESS WIRE)--VeriChip Corporation ("VeriChip") (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, and its development ...CHIP - PINK:RCRS
Digital Angel defends sale of VeriChip stake Finance and Commerce, MN - Nov 20, 2008 13 that it was selling its 45 percent stake in Florida?s VeriChip Corp., which makes an implantable RFID microchip for humans for patient care and ...CHIP - DIGAD
Dateline Pittsburgh: 11/5/08 Pittsburgh Post Gazette, PA - Nov 4, 2008 ClearCount Medical Solutions, which offers patient safety solutions for the operating room, closed its $4.1 million Series A financing round, ...
Recent News and Articles on the Keywords: rfid + diabetic + implanted Related to the article below (Last Update: 8/5/2008)
How Things Work: Multinational Monitor - Jul 26, 2008 A major emerging technology for consumer products is RFID (Radio Frequency Identification) systems. These systems, involving the attachment of tiny, ...
PROFNET EXPERT ALERTS: Health & Medicine StreetInsider.com (subscription), MI - Jul 10, 2008 Health: RFID Chips Used in Hospitals May Interfere with Life-Saving Equipment 5. Health: Skin Health and Stress 6. Health: Spinal Muscular Atrophy 7. ...
[PDF]Evaluation of HF RFID for Implanted Medical Applications E Freudenthal, D Herrera, F Kautz, C Natividad, A … - cs.utep.edu ... Ma, and M. Wu, ?The transcutaneous charger for implanted nerve stimulation ... in a patient
with diabetic gastroparesis,? Diabetic Medicine, vol ... 13] RFID Gazette ...
[CITATION] Security and Privacy of RFID for Biomedical Applications: A Survey E Stuart, M Moh, TS Moh - Rfid Handbook: Applications, Technology, Security, and …, 2008 - CRC
Suitability of NFC for Medical Device Communication and Power Delivery E Freudenthal, D Herrera, F Kautz, C Natividad, A … - Engineering in Medicine and Biology Workshop, 2007 IEEE …, 2007 - ieeexplore.ieee.org ... be provided by probes implanted within the brain [7 ... Mitigation of diabetic gastroparesis
through the use of ... Low frequency RFID (around 134 kHz) is used for ...
Lend me your arms: The use and implications of humancentric RFID - A Masters, K Michael - Electronic Commerce Research and Applications, 2007 - Elsevier ... An implantable RFID device for use by diabetes sufferers has ...Implanted in the abdominal
region, a wireless alarm unit carried by the patient continually ...
[PDF]Implantable RFID for The Health Industry A Marburger, J Coon, K Fleck, T Kremer - geocities.com ... VeriChip marketing representatives have approached diabetes, Alzheimer?s ... to Mike
Liard, an RFID analyst for ... million animals have been implanted)??But what ...
[PDF]A Note on ??berveillance? - MG Michael, K Michael - The Second Workshop on the Social Implications of National … - homelandsecurity.org.au ... 843-853. Diabetes News.(20 March 2007).?13 Diabetics Implanted With VeriMed RFID
Microchip At Boston Diabetes EXPO?, Medical News Today,< http://www. ...
FDA Approves Implantable Chip Used to Access Medical Records CME Medscape, M Connect, C Care, G Surgery, M … - medscape.com ... with chronic illnesses, such as diabetes, Alzheimer's disease ... is for patients with implanted medical devices ... In the future, the implantable RFID platform can be ...
Source: Google Scholar
18 Diabetic Patients Implanted With VeriMed RFID Microchip At Atlanta Diabetes EXPO
Article Date: 13 Mar 2007 - 0:00 PDT
VeriChip Corporation (Nasdaq: CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today it added 18 diabetic patients to its VeriMed Patient Identification System at an Atlanta Diabetes EXPO sponsored by the American Diabetes Association (ADA).
At the Diabetes EXPO, physicians implanted VeriMed RFID microchips in conference attendees who signed up for the voluntary procedure. The VeriMed Patient Identification System, which utilizes an implantable RFID microchip in combination with a handheld RFID scanner and a secure patient database, provides immediate access to important health information for patients who arrive at an emergency department unable to communicate.
Scott R. Silverman, Chairman and CEO of VeriChip, commented, "We believe the VeriMed Patient Identification System is an essential health care solution for at-risk patients, including diabetics, who tend to present with various co-morbidities and medications, and are more frequently admitted to emergency departments. Since the inception of the VeriMed System, we always knew that the diabetic community was in need of a way to communicate their medical information better and more frequently. We will continue to focus on diabetics and to enhance our relationship further with the American Diabetes Association. The Atlanta Diabetes EXPO provides us direct access so we can continue to educate an important target audience."
Article continues below and (thank you)
The Diabetes EXPO is a patient-driven tradeshow, including professional speakers and a variety of ADA program/event information, where exhibitors from pharmaceutical and medical device companies display beneficial products for diabetics. The Diabetes EXPO began in 1995 in Phoenix, Arizona, and has grown to 18, metro, major and mid-size cities around the U.S. The next event will be held in Boston on March 17, 2007.
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.
VeriChip Corporation is majority-owned by Applied Digital Inc. (Nasdaq: ADSX), which also owns a majority position in Digital Angel Corporation (Amex: DOC).
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.
Last Updated: 2007-03-12 8:26:13 -0400 (Reuters Health)
By Megan Rauscher
NEW YORK (Reuters Health) - Alternative medicines and therapies such as herbs, chiropractic care, and acupuncture, are widely used by couples seeking treatment for infertility, often in conjunction with prescription medicine, a study shows -- and the fertility specialist is often unaware of it.
It's possible that these therapies may interact with each other and impact the odds of a woman becoming pregnant, experts say, as the safety and efficacy of complementary medicines used to treat infertility or in conjunction with established treatments is unclear.
Dr. Marcin Stankiewicz, a fertility specialist at Flinders Medical Centre, Bedford Park, South Australia, said it's important to "tell your doctor/fertility specialist" about complementary medicine use. "Ask about ingredients and interactions with other drugs as well as safety."
In a survey of 97 new patients being seen at an infertility clinic, reported in the Australia & New Zealand Journal of Obstetrics and Gynecology, Stankiewicz and colleagues discovered that two-thirds reported using complementary medicine.
Nearly half of them said they had consulted with a complementary therapy provider, such as a chiropractor, acupuncturist, or naturopath.
Over three-quarters of the patients reported taking over-the-counter multivitamins, and about a quarter to one-third used herbal remedies including chamomile, echinacea, peppermint, and chaste tree berry.
It's been shown that the hormonal effects of chaste tree berry may promote the development of a serious condition called "ovarian hyperstimulation syndrome" in women having in vitro fertilization, Stankiewicz pointed out.
Use of complementary medicines and therapies declined 6 months after the initial visit to the infertility clinic, a follow up survey showed.
Only 29 percent of those surveyed at the infertility clinic said they talked to their doctor about their use of complementary medicine. In addition, a review of 200 patient records at the same clinic showed that use of complementary medicine was "poorly documented by clinical staff."
Better documentation, Stankiewicz said in a statement, "may contribute to identifying any positive or negative effects it (alternative medicine) has on fertility outcomes."
SOURCE: Australia & New Zealand Journal of Obstetrics and Gynecology, April 2007.
